Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 Trial


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Swords, RT; Savona, MR; Maris, MB; Erba, HP; Berdeja, JG; Foran, JM; Hua, Z; Faessel, HM; Dash, AB; Sedarati, F; Dezube, BJ; Medeiros, BC

Published Date

  • December 6, 2014

Published In

Volume / Issue

  • 124 / 21

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 56th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Francisco, CA

Conference Start Date

  • December 6, 2014

Conference End Date

  • December 9, 2014